Coherus BioSciences Inc (CHRS) — Financial Flexibility Index
Coherus BioSciences Inc (CHRS) has a Financial Flexibility Index of -0.92x as of June 2026. Free cash flow of $-119.98 Million (operating CF $-119.98 Million minus capex $0.00) represents -1% of total liabilities ($130.34 Million). Check CHRS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coherus BioSciences Inc Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Coherus BioSciences Inc across 14 annual periods. For the full cash flow conversion analysis, see CHRS cash flow metrics.
Annual Financial Flexibility Index for Coherus BioSciences Inc (2012–2025)
Year-by-year free cash flow to debt coverage for Coherus BioSciences Inc. Explore CHRS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | $-138.51 Million | $-138.51 Million | $197.33 Million | ▼ -1893.6% |
| 2024 | -0.04x | $-20.44 Million | $-20.44 Million | $580.52 Million | ▲ +83.4% |
| 2023 | -0.21x | $-174.60 Million | $-174.88 Million | $823.03 Million | ▲ +45.1% |
| 2022 | -0.39x | $-239.09 Million | $-241.12 Million | $618.26 Million | ▼ -522.3% |
| 2021 | -0.06x | $-36.14 Million | $-37.43 Million | $581.61 Million | ▼ -121.6% |
| 2020 | 0.29x | $161.38 Million | $154.15 Million | $560.67 Million | ▲ +111.9% |
| 2019 | 0.14x | $41.25 Million | $28.36 Million | $303.71 Million | ▲ +111.8% |
| 2018 | -1.15x | $-158.48 Million | $-159.27 Million | $138.06 Million | ▲ +22.5% |
| 2017 | -1.48x | $-195.71 Million | $-200.29 Million | $132.08 Million | ▲ +4.2% |
| 2016 | -1.55x | $-246.03 Million | $-252.54 Million | $159.13 Million | ▼ -233.0% |
| 2015 | -0.46x | $-101.83 Million | $-107.99 Million | $219.31 Million | ▼ -165.4% |
| 2014 | -0.17x | $-21.08 Million | $-23.93 Million | $120.46 Million | ▼ -199.5% |
| 2013 | 0.18x | $15.80 Million | $15.42 Million | $89.83 Million | ▲ +118.5% |
| 2012 | -0.95x | $-16.47 Million | $-18.25 Million | $17.34 Million | — |